Global Sacubitril Sodium API Market was valued at USD 0.15 Billion in 2022 and is projected to reach USD 0.35 Billion by 2030, growing at a CAGR of 12.7% from 2024 to 2030.
The Sacubitril Sodium API market has witnessed significant growth due to its critical role in the treatment of heart failure. Sacubitril sodium, a key component in combination with valsartan, is primarily used in the management of chronic heart failure with reduced ejection fraction (HFrEF). Its market has expanded as the healthcare industry emphasizes innovative treatments to improve patient outcomes in cardiovascular diseases.
One of the main drivers of the Sacubitril Sodium API market is the increasing prevalence of cardiovascular diseases worldwide. According to the World Health Organization (WHO), cardiovascular diseases remain the leading cause of death globally, and with rising cases, the demand for effective medications like Sacubitril Sodium has surged. As of recent data, the compound has been shown to significantly reduce hospitalizations and mortality in patients with heart failure, driving further market demand.
The market is also being influenced by ongoing advancements in drug formulations, as pharmaceutical companies continue to improve Sacubitril Sodium’s delivery systems. In addition, regulatory approvals and new partnerships between API manufacturers and large pharmaceutical companies are boosting the growth potential of the market.
On the supply side, the market has also seen a rise in API manufacturers in emerging markets, especially in Asia. With more manufacturers entering the market, there is an increase in the availability of high-quality Sacubitril Sodium APIs at competitive prices. This is particularly advantageous for markets with a large unmet need for affordable cardiovascular drugs.
Looking ahead, the Sacubitril Sodium API market is expected to maintain a steady growth trajectory, supported by the aging global population, a rise in heart disease diagnoses, and continuous innovation in drug formulations.
Get an In-Depth Research Analysis of the Global Sacubitril Sodium API Market Size And Forecast [2025-2032]
Raks Pharma
Mankind Pharma
Zhuhai Rundu Pharmaceutical Co.
Ltd
Zhejiang Hengkang Pharmaceutical
Amino Chemicals
Pharmirae Co.
Ltd.
Shenzhen Salubris Pharmaceuticals Co.
Ltd.
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Sacubitril Sodium API Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Sacubitril Sodium API Market
Tablets
Others
Based on Types the Market is categorized into Below types that held the largest Sacubitril Sodium API market share In 2023.
Above 98 %
Above 99 %
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Global, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Sacubitril Sodium API Market Research Analysis
1. Introduction of the Global Sacubitril Sodium API Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Sacubitril Sodium API Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Sacubitril Sodium API Market, By Type
6. Global Sacubitril Sodium API Market, By Application
7. Global Sacubitril Sodium API Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Sacubitril Sodium API Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/